NCT00005028View on ClinicalTrials.gov

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

bryostatin 1

DRUG

paclitaxel

Trial Locations (4)

17403

Wellspan Health - York Cancer Center, York

21204

Greater Baltimore Medical Center and Cancer Center, Baltimore

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

19111-2497

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00005028 - Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter